ProfileGDS4132 / 206622_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 69% 73% 80% 78% 76% 71% 74% 71% 71% 78% 74% 74% 72% 73% 79% 72% 76% 73% 75% 70% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101205.71669
GSM201543Muscle PCOS pioglitazone 121215.5173
GSM201544Muscle PCOS pioglitazone 161285.00280
GSM201545Muscle PCOS pioglitazone 201279.47478
GSM201829Muscle PCOS pioglitazone 231254.68476
GSM201830Muscle PCOS pioglitazon 251222.32971
GSM201831Muscle PCOS pioglitazone 271238.81974
GSM201832Muscle PCOS pioglitazone 31205.12371
GSM201833Muscle PCOS pioglitazone 41202.58471
GSM201834Muscle PCOS pioglitazone 81263.91778
GSM201835Muscle PCOS after pioglitazone 102228.40374
GSM201836Muscle PCOS after pioglitazone 122228.35474
GSM201837Muscle PCOS after pioglitazone 162200.87872
GSM201838Muscle PCOS after pioglitazone 202222.773
GSM201839Muscle PCOS after pioglitazone 232273.27279
GSM201840Muscle PCOS after pioglitazone 252227.47572
GSM201841Muscle PCOS after pioglitazone 272232.88176
GSM201842Muscle PCOS after pioglitazone 32198.71173
GSM201843Muscle PCOS after pioglitazone 42234.3675
GSM201844Muscle PCOS after pioglitazone 82212.13270